蒙特卢卡斯特作为类风湿性关节炎患者的辅助疗法的有效性:一项随机对照研究
Basma M Ahmed1, Noha O Mansour1, Rehab A Sallam2
1Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
International immunopharmacology
|September 19, 2023
概括
蒙特卢卡斯特显著改善了类风湿性关节炎疾病活动和生活质量,当添加到非生物疾病修饰性抗风湿药物 (nDMARDs) 时. 这种组合疗法还减少了炎症标志物,表明增强了抗风湿作用.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特征是关节炎症和损伤.
- 非生物修饰性抗风湿药物 (nDMARDs) 是关节炎的标准治疗方法,但许多患者需要额外的治疗来控制疾病.
研究的目的:
- 在患有类风湿性关节炎的患者中,对现有的nDMARD疗法添加蒙特卢卡斯特的疗效进行研究.
- 评估蒙特卢卡斯特对 RA 患者疾病活性,生活质量和特定炎症标志物的影响.
主要方法:
- 进行了一项单中心,随机,双盲,安慰剂控制的试验.
- 接受nDMARD治疗的中度至重度疾病活动的成人RA患者随机分组接受蒙特卢卡斯特 (每天10毫克) 或安慰剂16周.
- 主要终点是28关节疾病活性评分 (DAS28) 的变化;次要终点包括生活质量 (HAQ-DI) 和血清VCAM-1水平.
主要成果:
- 与安慰剂组 (0.2,p < 0.01) 相比,蒙特卢卡斯特组显示DAS28 (-1.5) 显著下降.
- 接受蒙特卢卡斯特治疗的患者生活质量显著改善 (p < 0.01) 和血清VCAM-1水平降低 (p = 0.004).
- 在安慰剂组中没有观察到生活质量的显著改善 (p = 0.08).
结论:
- 蒙特卢卡斯特与nDMARDs的同时使用增强了RA患者的抗风湿作用.
- 蒙特卢卡斯特在减少疾病活动和改善RA患者的生活质量方面表现出临床疗效.
- 这项研究表明蒙特卢卡斯特可以作为一种潜在的辅助疗法来治疗类风湿性关节炎.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
343
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
343
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
295
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
295
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K